Would love to see double blinded prurisol data come out, on the brink of "any day now". And I like the timing of todays PR, put prurisol data out in pre-market Leo!!
Looking very good for brilacidin. Wonder which one of the CDA's will partner for the FDA meeting.
Message in reply to:
I wonder if this "data analysis conclusion" held up the FDA data submission and meeting, and its BTD verdict. (I think the clock starts upon submission: 60 days for BTD decision.) Company doesn't say here. We do know from March that the company was still "preparing for an FDA meeting", pulling together the CSR and a briefing package.
It's no small job getting everything together. And now we're ready. Todays PR may not be a market mover but it certainly solidifies that they're ready for the next step. Possibly branching out into the EU as well.